Collectively, the in vivo and in vitro data suggest that OCP exposure suppresses insulin secretion and promotes hyperglycemia, perhaps in part by altering β-cell function and promoting β-cell death, although the specific mechanism of action remains unclear (Fig. 2, Fig. 3B, Fig. 7B, and Fig. 8). The gene discussed is INS; the disease is Hyperglycemia.